Job offersmore »

Tweeting Growers

Top 5 - yesterday

Top 5 - last week

Top 5 - last month

Exchange ratesmore »

Australia: The Hydroponics Company appoints CCO

The Hydroponics Company has appointed Mrs Debbie Ormsby as Chief Commercial Officer. Mrs. Ormsby brings significant pharmaceutical and biotech expertise with extensive experience in end to end product commercialisation within the pharmaceutical markets. Her career spans a variety of senior leadership positions at a country, regional and global level including Managing Director, Meda Pharmaceuticals, General Manager, The Medicines Company, Regional Medical Director, Actelion Pharmaceuticals and Global Study Leader roles for both Roche Products and The Wellcome Foundation. Mrs. Ormsby is a trained pharmacist and a registered member of The Royal Pharmaceutical Society and expects to complete her MBA (Executive) from the AGSM in 2018.

In 2016 Mrs Ormsby undertook a consulting assignment assessing the global medicinal cannabis market and provided strategic advice which supported the subsequent legislation of medicinal cannabis in Victoria.

Mrs Ormsby stated she is excited to join THC at this stage of rapid expansion into the growing Australian market and looks forward to leveraging her pharmaceutical industry experience to facilitate patient access to medicinal cannabis for therapeutic use. Her goal is to focus on the objectives and priorities of the company that will achieve optimal results for all stakeholders and make a meaningful difference to the lives of Australian patients.

THC’s Group Chief Executive Officer, David Radford said: “We are delighted to have an executive of Debbie’s calibre with her impressive track record and enormous commercial experience join THC. Her career in the development of pharmaceutical markets both locally and internationally bring the required skills to help THC develop innovative solutions that bring the prescribing physicians and patients together to facilitate the access to high quality medicinal cannabis solutions."

For more information:
The Hydroponics Company
Suite 305, Level 3, 35 Lime Street
Sydney, NSW 2000 Australia

Publication date: 11/28/2017



Other news in this sector:

1/16/2018 CAN (BC): Aphria acquires fellow MJ grower Broken Coast
1/16/2018 Canadian marijuana producers go on hiring spree
1/15/2018 Video: How to ready over 1M sq.ft. of greenhouse for cannabis
1/12/2018 CAN (ON): Aphria partners with Double Diamond to grow cannabis
1/11/2018 Paraguay legalizes marijuana for medicinal and scientific use
1/10/2018 CAN (ON): MMJ grower receives approval to double production capacity
1/10/2018 Germany: Nuclear bunker becomes marijuana farm
1/9/2018 US (CA): CDFA now accepting temporary cannabis licensing applications
1/8/2018 Australia to permit medicinal cannabis exports
1/5/2018 Denmark: Tomato grower Alfred Pedersen & Søn in cannabis joint-venture
1/5/2018 US (FL): Liberty buys 200,000 sq.ft. greenhouse and processing facilities
1/5/2018 US: Trump administration move 'could threaten marijuana legalization'
1/4/2018 CAN (BC): True Leaf to construct MMJ facility on 40-acre site
1/3/2018 Aurora purchases more than half a million CanniMed shares
1/3/2018 US (MI): TheraCann cancels plans for marijuana facility
1/3/2018 CAN (ON): 'World's biggest pot farm' prepares to expand
1/3/2018 Recreational cannabis legalised in California
1/2/2018 US (NV): Marapharm to build third facility in Las Vegas
12/22/2017 US (ME): Future Farm expands hemp farm operation by 100 acres
12/21/2017 "Aurora takeover better for CanniMed shareholders than Newstrike deal"